Cancer Epidemiology Biomarkers & Prevention: 2 (3)

Intake of specific carotenoids and lung cancer risk.

L Le Marchand, J H Hankin, L N Kolonel, G R Beecher, L R Wilkens and L P Zhao

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 183-187;
Attributable risk for oral cancer in northern Italy.

E Negri, C La Vecchia, S Franceschi and A Tavani

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 189-193;
Urinary excretion of nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for nasopharyngeal carcinoma in southern China.

Z Yi, H Ohshima, G Bouvier, P Roy, J Zhong, B Li, I Brouet, G de Thé and H Bartsch

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 195-200;
Histopathological predictors of breast cancer death among Caucasians and Japanese in Hawaii.

C M Higuchi, S A Serxner, A M Nomura and G N Stemmermann

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 201-205;
Human papillomaviruses and cervical neoplasia in South Carolina.

A L Coker, G R Jenkins, M S Busnardo, J C Chambers, L Z Levine and L Pirisi

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 207-212;
Epstein-Barr virus-associated gastric adenocarcinoma among Japanese Americans in Hawaii.

D Shibata, D Hawes, G N Stemmermann and L M Weiss

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 213-217;
The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.

G W Comstock, G B Gordon and A W Hsing

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 219-221;
Detection of mutagens in cervical mucus in smokers and nonsmokers.

E A Holly, R D Cress, D K Ahn, D A Aston, J J Kristiansen, R Wu and J S Felton

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 223-228;
Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation.

S Gupta-Burt, H Shamkhani, E Reed, R E Tarone, C J Allegra, L H Pai and M C Poirier

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 229-234;
Urinary and erythrocyte polyamines during the evaluation of oral alpha-difluoromethylornithine in a phase I chemoprevention clinical trial.

L Pendyala, P J Creaven and C W Porter

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 235-241;
Evaluation of alpha-difluoromethylornithine as a potential chemopreventive agent: tolerance to daily oral administration in humans.

P J Creaven, L Pendyala and N J Petrelli

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 243-247;
Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers.

I M Jones, D H Moore, C B Thomas, C L Thompson, C L Strout and K Burkhart-Schultz

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 249-260;
Predictors of long-term smoking cessation in head and neck cancer patients.

E R Gritz, C R Carr, D Rapkin, E Abemayor, L J Chang, W K Wong, T R Belin, T Calcaterra, K T Robbins and G Chonkich

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 261-270;
PSK as a chemopreventive agent.

H Kobayashi, K Matsunaga and M Fujii

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 271-276;
Risk factors for childhood brain tumors.

R R Kuijten and G R Bunin

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 277-288;
Measurement of oxidative stress status in humans.

W A Pryor

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 289-292;
Rising incidence of colon cancer in Shanghai.

S S Devesa, F Jin, W Zheng, W J Blot, J F Fraumeni Jr and Y T Gao

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 293-294;
Position statement of the American Urological Association.

Cancer Epidemiol Biomarkers Prev May 1 1993 2 (3) 295-295;

Main menu

User menu

Search

Table of Contents

Articles

Info for

About Cancer Epidemiology, Biomarkers & Prevention